Quay lại
Giá Hansoh Pharmaceutical Group Company Limited (03692.HK)
Biểu đồ giá cổ phiếu 03692.HK
HANSOH PHARMA (03692.HK)
Hansoh Pharmaceutical Group Company Limited
HK$40.22
-0.64%
$-0.25
Nghỉ giữa phiên: Jan 22, 16:00:00 HKT
A+
Kết quả cuối cùng
Thống kê chính
Giá đóng cửa trước
$40.5
Giá mở cửa
$40.48
Phạm vi ngày
$40.16 - $41.2
Phạm vi 52 tuần
$15.96 - $44.22
Khối lượng
1.9M
Khối lượng trung bình
7.8M
EPS (TTM)
0.89
Tỷ suất cổ tức
--
Vốn hóa thị trường
$239.1B
HANSOH PHARMA là gì?
Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 9,313 full-time employees. The company went IPO on 2019-06-14. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The firm mainly conducts its business in the domestic market.
Đặc điểm
Chiến lược giao dịch
Tài nguyên
© 2025 Finture Development Limited. All rights reserved
